Home
LiteratureArticle Details
PMID: 19571292
Published · ppublish
English
Letter
Comment
Rosuvastatin in patients undergoing hemodialysis.
Abstract
暂无摘要
MeSH Terms
Cardiovascular Diseases/etiology,prevention & control
Confounding Factors, Epidemiologic
Fluorobenzenes/therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
Hyperphosphatemia/complications
Hypertrophy, Left Ventricular/complications
Kidney Failure, Chronic/drug therapy
Phosphorus/blood
Pyrimidines/therapeutic use
Renal Dialysis/adverse effects
Rosuvastatin Calcium
Sulfonamides/therapeutic use
Chemicals
Fluorobenzenes
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pyrimidines
Sulfonamides
Phosphorus
Rosuvastatin Calcium
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2009-07-02
Pages
93; author reply 94-5
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
Analysis Services
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
